Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), alanine transaminase/aspartate transaminase (ALT/AST), and body mass index (BMI), and other indicators of metabolism, are all regarded as important factors related to the risk of NAFLD and contribute to the diagnosis (5–7). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.